![衛福部核可之細胞治療執行單位 [持續更新]](https://biomaptw.com/media/k2/items/cache/753a82091bdf93df272697e1f26229c2_XL.jpg)
Program Agenda 2022 高雄國際癌症研討會
Program Agenda 2022 高雄國際癌症研討會
| 04 月 23 日 (星期六) Saturday , 23 April | |||
| Time | Topic | Speaker | Moderator |
| 07:30 | Registration | ||
| 08:15-08:30 | Opening Remarks | ||
| 08:30-09:00 | Recent development in breast cancer research in CMU |
Mien-Chie Hung 洪明奇 |
Ming-Feng Hou 侯明鋒 |
| 09:00-09:30 | Androgen regulated microRNA-887 targets cation channel TMEM38B to enhance breast cancer growth and metastasis. |
Lu-Hai Wang 王陸海 |
Mien-Chie Hung 洪明奇 |
| 09:30-10:00 | ROS-modulating natural products show antiproliferation to breast cancer cells |
Hsueh-Wei Chang 張學偉 |
Lu-Hai Wang 王陸海 |
| 10:00-10:30 | Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes |
Tian-Lu Cheng 鄭添祿 |
Shyng-Shiou Yuan 袁行修 |
| 10:30-10:50 | Coffee Break | ||
| 10:50-11:20 | Bone Health Care in Patients with Breast Cancer |
Chi-Cheng Huang 黃其晟 |
King-Jen Chang 張金堅 |
| 11:20-11:50 | From consistent OS benefit to clinical practice of current HR+ HER2- mBC treatment strategy with CDK4/6i |
Chun-Yu Liu 劉峻宇 |
Ling-Ming Tseng 曾令民 |
| 11:50-12:20 | New Era of Endocrine therapy in HR+ HER2- Advanced Breast Cancer |
Ta-Chung Chao 趙大中 |
Shin-Cheh Chen 陳訓徹 |
| 12:20-13:30 | Lunc |
| 13:30-14:00 | Novel Trop-2 ADC Sacituzumab Govitecan in cancer therapy |
Wei-Pang Chung 鍾為邦 |
Jyh-Cherng Yu 俞志誠 Dar-Ren Chen 陳達人 |
| 14:00-14:30 | New role of immunotherapy in triple negative breast cancer: from late to early |
Rina Hui | Chiun-Sheng Huang 黃俊升 Yen-Shen Lu 盧彥伸 |
| 14:30-15:00 | Emerging Evidence with Immuno-Oncology in TNBC |
Kun-Ming Rau 饒坤銘 |
Shyr-Ming Sheen-Chen 沈陳石銘 |
| 15:00-15:30 | Talazoparib in patients with HER2-advanced breast cancer and a germline BRCA1/2 mutation: Experience from clinical trial to real-world study |
Kyung-Hun Lee | Tsui-Fen Cheng 鄭翠芬 Yao-Lung Kuo 郭耀隆 |
| 15:30-16:00 | PARB inhibitor, a partner or unitary in breast cancer treatment? |
Jun-Ping Shiau 蕭君平 |
Shou-Tung Chen 陳守棟 |
| 16:00-16:20 | Coffee Break | ||
| 16:20-16:50 | The role of pegylated liposomal doxorubicin as adjuvant and neoadjuvant in early breast cancer |
Chi-Cheng Huang 黃其晟 |
Ming-Yang Wang 王明暘 Guo-Shiou Liao 廖國秀 |
| 16:50-17:20 | Transforming clinical treatment in HER2 Positive Breast Cancer with PHESGO |
An-Chieh Feng 馮安捷 |
Ming-Shen Dai 戴明燊 Dah-Cherng Yeh 葉大成 |
| 17:20-17:50 | Focus on HER2+ mBC patients How to Change Her Destiny by Novel ADC Therapy? |
Liang-Chih Liu 劉良智 |
Hsien-Kun Chang 張献崑 |
| 17:50-18:00 | Panel Discussion & Closing |
Program Agenda 2022 高雄國際癌症研討會
| 04 月 24 日 (星期日) Sunday , 24 April | |||
| Time | Topic | Speaker | Moderator |
| 08:30-09:00 | Bridging the gap: ABC6 (Advance Breast Cancer) and ABC Global Alliance |
Shinji Ohno 大野真司 |
Hong-Tai Chang 張宏泰 Ching-Kuen Pan 潘慶坤 |
| 09:00-09:30 | Is HER2-lopositive or ER-low-positive new subtype of triple negative breast cancer? |
Takashi Ishikawa 石川孝 |
Chao-Ming Hung 洪朝明 Kun-Ming Rau 饒坤銘 |
| 09:30-10:00 | Treatment strategy update for MBCs post CDK4/6 inhibitors |
Tetsu Hayashida 林田哲 |
Chen-Hsiang Chang 張振祥 Kuo-Ting Lee 李國鼎 |
| 10:30-10:50 | Coffee Break | ||
| 10:20-10:50 | Breast Cancer Risks among Female Health Professionals |
Hui-Min Hsieh 謝慧敏 |
Chih-Jen Huang 黃志仁 |
| 10:50-11:20 | Gut microbiota in premenopausal breast cancer: from the perspective of prevention, detection, and treatment response |
Chih-Po Chiang 江誌博 |
Ming-Yii Huang 黃旼儀 |
| 11:20-11:50 | Dissecting the expression of epigenetic modulator as a guideline for determining combined RT therapy in LN+ TNBC patients |
Mei-Ren Pan 潘美仁 |
Fu Ou-Yang 歐陽賦 |
| 11:50-12:20 | Targeting focal adhesion kinase as an alternative antiangiogenesis therapy in triple-negative breast cancer |
Chi-Wen Luo 羅啟文 |
Shen-Liang Shih 施昇良 |
| 12:20-12:30 | Closing | Fang-Ming Chen 陳芳銘 |
※醫院門口管制措施：
(1) 高醫體系醫院人員：
攜帶 "醫院識別證 (員工通道)" or "健保卡／身分證 (民眾通道)"，過卡驗證成功後才可入院。
(2) 高雄醫學大學人員：
報名時須填正確 "身分證字號"，由大會協助登入「來院人員登錄系統 」
以"健保卡／身分證 (民眾通道)"驗證，驗證成功後才可入院。
並配合最新防疫規定：需檢附疫苗接種紀錄 (2劑 or 3劑)或 參與日前3日內採檢陰性報告(核酸或抗原)。
(3) 院外人員：
報名時須填正確 "身分證字號"，由大會協助登入「來院人員登錄系統 」
以"健保卡／身分證 (民眾通道)"驗證，驗證成功後才可入院。
並配合最新防疫規定：需檢附 疫苗接種紀錄 (2劑 or 3劑)或 參與日前3日內採檢陰性報告(核酸或抗原)。
最新防疫規定將配合疫情指揮中心，進行滾動式調整。
日期 & 時間
2022 年 4 月23 日(六) - 4月 24 日(日)
地點 & 地址
主辦單位
聯絡資訊
